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The activation of most paramyxovirus fusion proteins (F proteins) requires not only cleavage of F0 to F1 and
F2 but also coexpression of the homologous attachment protein, hemagglutinin-neuraminidase (HN) or
hemagglutinin (H). The type specificity requirement for HN or H protein coexpression strongly suggests that
an interaction between HN and F proteins is required for fusion, and studies of chimeric HN proteins have
implicated the membrane-proximal ectodomain in this interaction. Using biotin-labeled peptides with se-
quences of the Newcastle disease virus (NDV) F protein heptad repeat 2 (HR2) domain, we detected a specific
interaction with amino acids 124 to 152 from the NDV HN protein. Biotin-labeled HR2 peptides bound to
glutathione S-transferase (GST) fusion proteins containing these HN protein sequences but not to GST or to
GST containing HN protein sequences corresponding to amino acids 49 to 118. To verify the functional
significance of the interaction, two point mutations in the HN protein gene, I133L and L140A, were made
individually by site-specific mutagenesis to produce two mutant proteins. These mutations inhibited the fusion
promotion activities of the proteins without significantly affecting their surface expression, attachment activ-
ities, or neuraminidase activities. Furthermore, these changes in the sequence of amino acids 124 to 152 in the
GST-HN fusion protein that bound HR2 peptides affected the binding of the peptides. These results are
consistent with the hypothesis that HN protein binds to the F protein HR2 domain, an interaction important
for the fusion promotion activity of the HN protein.
Infection by the paramyxovirus Newcastle disease virus
(NDV) requires two glycoproteins, the attachment protein and
the fusion protein (F protein) (reviewed in reference 11). The
attachment protein, hemagglutinin-neuraminidase (HN), binds
to sialic acid-containing receptors, and the F protein directs
membrane fusion between the viral and the cellular mem-
branes. Unlike many viral F proteins, paramyxovirus F proteins
do not require the acid pH of endosomes for the activation of
fusion activity; thus, other mechanisms for F protein activation
must be invoked (7). Because of this acid pH independence,
infected cells expressing both the HN and the F proteins can
fuse with adjacent cells to form multinuclear cells or syncytia,
a process that is assumed to be similar to virus-cell fusion
(reviewed in reference 11).
The NDV F protein is synthesized as a precursor, F0 (11),
that must be proteolytically cleaved to activate F protein fusion
activity. Cleavage at amino acid 117 produces disulfide-linked
F2 and F1 polypeptides derived from the amino-terminal and
carboxyl-terminal domains of F0, respectively (reviewed in ref-
erence 11). The F1 polypeptide has one and perhaps two fusion
peptides (18, 19). Upon initiation of fusion, fusion peptides are
thought to insert into target membranes, docking the protein
to these membranes (reviewed in references 6, 7, and 19).
Paramyxovirus F1 polypeptides have two heptad repeat (HR)
regions, one (HR1) located just carboxyl terminal to the more
amino-terminal fusion peptide and the other adjacent to the
transmembrane domain (HR2) (reviewed in reference 11).
Studies of peptides with sequences of these HR domains (9, 12,
22, 38, 40, 41), characterization of mutations within these do-
mains (16, 23, 24, 27), and results of similar studies of human
immunodeficiency virus and influenza virus (6) have led to the
hypothesis that F proteins are synthesized and transported to
cell surfaces in a metastable conformation in which the HR
domains are not associated and the fusion peptides are masked
(6, 19, 37). Upon fusion activation, F proteins are thought to
undergo a series of conformational changes that result in the
insertion of fusion peptides into target membranes and the
interaction of the HR1 and HR2 domains to form a very stable
complex (1). The formation of this complex is thought to pull
target and attack membranes in close proximity, allowing sub-
sequent fusion events (1, 42).
In most paramyxovirus systems, F protein cleavage is not
sufficient to activate these conformational changes in the F
protein; rather, coexpression of the attachment protein is also
required (8, 11). The HN protein provides more than an at-
tachment or membrane-docking function, since mutants with
mutations in the HN protein can retain attachment activity but
are defective in fusion promotion (21, 25, 26, 28). It has been
proposed that the attachment of the HN protein to its receptor
serves to activate the F protein (11), but the nature of this
activation is poorly understood. The HN protein and the F
protein must be from the same virus, with a few exceptions,
indicating that virus-specific interactions between HN and F
proteins (8) are required for fusion directed by the F protein.
Indeed, an interaction has been shown in several systems (4,
13, 20, 29, 39). It seems likely that this interaction is somehow
linked to F protein activation.
The domain of the HN protein that interacts with the F
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protein has not been directly identified, but studies of hybrid
HN proteins by three different laboratories have all implicated
the membrane-proximal ectodomain in virus-specific fusion
promotion activity (5, 31, 36). With this approach, the speci-
ficity for the NDV F protein has been mapped to amino acids
55 to 141 of the NDV HN protein, a sequence adjacent to the
HN protein transmembrane domain of this type 2 glycoprotein
(5). Because the F protein HR2 domain is adjacent to the
transmembrane domain and because the HR2 domain should
remain uncomplexed with the HR1 domain prior to activation,
we examined whether there was a specific interaction between
peptides with sequences from the F protein HR2 domain and
the HN protein membrane-proximal ectodomain. We report a
specific interaction between the F protein HR2 domain and an
HN protein domain from amino acids 124 to 152. That this
region of the HN protein is important for fusion promotion is
shown by the properties of mutant proteins with alterations in
this domain.
MATERIALS AND METHODS
Cells and vectors. Cos-7 cells, obtained from the American Type Culture
Collection, were maintained in Dulbecco’s modified Eagle’s medium supple-
mented with nonessential amino acids, vitamins, penicillin-streptomycin, and
10% fetal calf serum. The NDV HN and F protein genes were expressed in Cos-7
cells by using pSVL (Pharmacia) as previously described (27).
Peptides. Peptide HR2a-B corresponds to a 20-amino-acid segment (amino
acids 477 to 496) of the HR2 domain of the F protein (Fig. 1A) (40). Peptide
HR2b-B corresponds to a 40-amino-acid segment (amino acids 452 to 491) of the
HR2 domain of the F protein (Fig. 1A). Both peptides were obtained from Tufts
University School of Medicine Peptide Core Facility. Both peptides included
three glycine residues at the amino terminus of the NDV sequence, and a biotin
residue was covalently linked to the amino terminus of each peptide. The pep-
tides were purified at the Tufts University School of Medicine Peptide Core
Facility by high-pressure liquid chromatography.
GST-HN fusion proteins. Glutathione S-transferase (GST) fusion protein
genes were constructed with pET-42a() (Novagen). HN protein sequences
inserted at the carboxyl terminus of the coding region for GST were generated
by PCRs with start primers containing a BamHI site and end primers containing
a translation stop codon followed by an EcoRI site. Start primers were as follows:
START A, GCATATGGATCCGAGGCTAGCACA; START 65, AGCATAC
CAACTGCGGGATCCAGGGCA; START 77, TCTGCACTCGGATCCAAT
CAG; START 97, TGAATCTCCGTTGGGATTCCTAAA; and START 124,
AACAGCGGATCCGGGGCACCTGTT. End primers were as follows: End B,
TTCTTGGAATTCAGATCAATAGAATGA; End 76, CCTATCTACGAATT
CCTGCTAGGAACCGAG; End 93, GATTCGGTGAATTCCAATGCCTACG
GAGAT; End 118, CCCACACCCGAATTCTCATGCAGCTCC; and End 131,
GTTCTTTACCGAATTCCCCGATCTAATCTGG. START A is designed to
link amino acid 49 in the HN protein sequence to the carboxyl terminus of GST.
End B corresponds to amino acid 152 in the HN protein sequence. Other
numbers in the start and end primers refer to amino acids in the HN protein
sequence. PCR products were ligated to BamHI/EcoRI-cut pET-42a() DNA
FIG. 1. HN and F protein peptide sequences. (A) Positions in the intact F protein of sequences represented by two synthetic peptides, HR2a
and HR2b. The top line diagrams the membrane-proximal ectodomain of the F protein. The position of the transmembrane domain (TM) is
indicated by the hatched box. The sequences included by peptide HR2a-B (amino acids 477 to 496) and by peptide HR2b-B (amino acids 452 to
491) are indicated. (B) Positions in the HN protein of sequences cloned in frame at the carboxyl terminus of the GST fusion protein. The top line
represents the HN protein membrane-proximal ectodomain. The position of the TM is indicated by the hatched box. The HN protein sequences
in different GST fusion proteins are shown below. Position A corresponds to amino acid 49, while position B corresponds to amino acid 152. The
numbers in the B series of GST fusion proteins refer to amino acid at the beginning of the HN protein sequence in each GST fusion protein. The
numbers in the A series of GST fusion proteins refer to the amino acid at the end of the HN protein sequence.
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and transformed into HB101 competent cells (Gibco/BRL/Life Technologies).
GST-HN fusion protein sequences were verified by DNA sequencing. The plas-
mids were then introduced into BL21(DE3) (Novagen) for the preparation of
fusion proteins.
GST-HN fusion proteins were prepared according to protocols specified by
Novagen. Briefly, a log-phase culture of BL21(DE3) was induced to express the
GST protein by exposure to isopropyl--D-thiogalactopyranoside (IPTG) (final
concentration, 0.4 mM) for 2 h. The bacteria were collected by centrifugation,
resuspended in gel sample buffer (17% glycerol, 0.1 M Tris-HCl [pH 6.8], 0.06%
bromophenol blue, 5% sodium docecyl sulfate, 1 M -mercaptoethanol), and
boiled.
Peptide binding to GST-HN fusion proteins. Extracts of bacteria expressing
GST fusion proteins were diluted in gel sample buffer and loaded onto 10%
polyacrylamide gels. After electrophoresis, the gels were equilibrated in transfer
buffer (25 mM Tris, 192 mM glycine, 5% methanol [pH 8.2]) and transferred to
Immobilon P (Millipore Corp.) membranes by electrophoresis. The membranes
were blocked in phosphate-buffered saline (PBS) containing 0.5% Tween 20
(PBS-Tween 20) and 10% nonfat dried milk for 2 h at room temperature or
overnight at 4°C. The membranes were washed in PBS-Tween 20 and incubated
with either HR2a-B peptide or HR2b-B peptide (7 g/ml) diluted in PBS-Tween
20 containing 0.5% nonfat milk for 1 h at room temperature. The membranes
were washed and then incubated with Neutravidin that was coupled to horse-
radish peroxidase (5 g/ml) (Pierce Corp.) and that was diluted in PBS-Tween
containing 0.5% nonfat milk for 1 h at room temperature. The membranes were
washed extensively, and bound peptides were detected by using an enhanced
chemiluminescence Western blotting detection reagent system (Amersham).
For experiments with undenatured, purified fusion proteins, GST-HN fusion
proteins were purified from bacterial cell extracts by using glutathione affinity
columns (Novagen).
Site-specific mutagenesis. The HN protein gene mutants were generated by
PCR with the appropriate oligomer for each mutation. Amino acid 133 was
changed from an isoleucine to a leucine, and amino acid 140 was changed from
a leucine to an alanine. The forward primer, SEB 21 (AACTGCTCCTCAGTG
GATGTTGC), bound to the multiple cloning cassette in the vector. Reverse
primers contained the mutation and an SpeI site: I133L, TCACTAGTATCAT
CCACAATAAGTTCTTTACCTATCCCCCCGAGGTAATCTGG; and L140A,
TCACTAGTATCATCCACAATTGCTTCTTTACC. PCR products were di-
gested with XhoI/SpeI, and the 1.25-kb product was gel purified. The HN protein
gene was reassembled in pSVL by using the XhoI/SpeI PCR product and the
SpeI/SpeI 4.9-kb fragment corresponding to the 3 end of the HN protein gene.
The genes of the mutant DNAs were sequenced in their entirety to verify the
proper orientation of the SpeI/SpeI fragment and to determine that the rest of
the gene remained unchanged by the mutagenesis reaction. Mutants are named
in the single-letter code, and the names indicate the amino acid in the wild type,
the position of the change, and the amino acid in the mutant.
Transfections. Transfections with Lipofectamine (Gibco/BRL/Life Technolo-
gies) were done essentially as recommended by the manufacturer. Cos-7 cells
were plated at 3  105 per 35-mm plate. At 20 to 24 h later, the cells were
transfected. For each 35-mm plate, a mixture of DNA (0.5 to 1.5 g, depending
upon the experiment) in 0.1 ml of OptiMem (Gibco/BRL/Life Technologies) and
10 l of transfection reagent in 0.2 ml of OptiMem was incubated at room
temperature for 40 min, diluted with 0.7 ml of OptiMem, and added to a plate
that had been washed twice with 2 ml of OptiMem. The cells were incubated for
5 h, DNA-Lipofectamine was removed, and 2 ml of supplemented Dulbecco’s
modified Eagle’s medium was added.
Flow cytometry. Cells transfected with 0.75 g of plasmid DNA/35-mm plate
for 48 h were removed from the plates after trypsin (50 g/ml) digestion, washed
in PBS containing 1% bovine serum albumin and 0.02% azide (fluorescence-
activated cell sorting [FACS] buffer), and incubated with anti-NDV antibody
(1:2,500 dilution) for 1 h on ice. After being washed three times with FACS
buffer, the cells were incubated for 1 h on ice with goat anti-rabbit immunoglob-
ulin G coupled to Alexa dye 488 (Molecular Probes) (1:1,400 dilution). After
being washed three times with FACS buffer, the cells were resuspended in PBS
containing 2% paraformaldehye and subjected to flow cytometry (University of
Massachusetts Medical School Flow Cytometry Facility). The background was
cells transfected with vector alone and incubated with both primary and second-
ary antibodies.
Fusion assays. (i) Syncytium formation. Cos-7 cells were cotransfected with
wild-type or mutant HN protein genes (0.75 g/plate) and the wild-type F
protein gene (0.75 g/plate). At 24 h posttransfection, the cells were removed
from the plates with trypsin (Gibco/BRL/Life Technologies), mixed with twice
the number of untransfected Cos-7 cells, and replated at 5  105 cells/35-mm
plate. The number of nuclei in 40 fusion areas was counted to determine the
average size of the syncytia at each time point as previously described (26).
Values obtained after transfection with the vector alone were subtracted.
(ii) Content mixing. Content mixing was measured by using modifications of a
previously described protocol (14). Briefly, a plasmid encoding a tetracycline-
responsive transcriptional activator, tTA (Clontech), was transfected (1 g/
35-mm plate) with pSVL-HN (0.75 g/35-mm plate) and pSVL-F (0.75 g/
35-mm plate) DNAs. A separate population of cells was transfected 24 h later
with a plasmid encoding the -galactosidase protein under the control of the
tetracycline-responsive transcriptional activator (Clontech) (1 g/35-mm plate).
After 20 h, the cells transfected with the plasmid encoding the -galactosidase
protein were removed from the plate with trypsin and placed on top of the HN
protein- and F protein-expressing cells. At 47 h posttransfection of the HN
protein- and F protein-expressing cells, when fusion was evident, the monolayers
were lysed (Promega cell lysis buffer), and extracts were assayed for -galacto-
sidase activity. Activity due to background fusion typical of Cos-7 cells was
measured after transfection of cells with comparable amounts of the vector
alone. Values obtained were subtracted from values obtained with cells express-
ing wild-type or mutant HN proteins and wild-type F protein.
RESULTS
GST-HN fusion proteins with sequences from the mem-
brane-proximal domain of the HN protein. Sequences encod-
ing various lengths of the membrane-proximal region of the
NDV HN protein, from amino acids 49 to 152, were inserted in
frame at the carboxyl terminus of the GST protein sequence as
described in Materials and Methods (Fig. 1B). This region of
the ectodomain of the HN protein was chosen for two reasons.
First, mutational analyses of the NDV HN protein, from amino
acids 88 to 110, have shown this region to be important for
fusion promotion activity (28). Second, a hybrid HN protein
with sequences from the NDV HN protein and the PIV3 HN
protein has implicated this region in type-specific interactions
with the NDV F protein (5). The GST fusion protein contain-
ing the sequence from the entire membrane-proximal domain
was designated GST-AB (Fig. 1). This amino acid sequence
contains a cysteine residue (amino acid 123) which could in-
terfere with the formation or recovery of the fusion protein.
Thus, a second fusion protein in which the cysteine codon was
replaced with a tryptophan codon was also produced (GST-
AB-W). Tryptophan was chosen as the replacement codon
since some strains of NDV encode an HN protein with tryp-
tophan at this position.
Other GST-HN fusion proteins were also produced with
various sequences from this region of the HN protein (Fig. 1).
GST-HN fusion proteins with overlapping deletions of the
amino-terminal region of the AB sequence were made (GST-
65B, GST-77B, GST-97B, and GST-124B) (numbers in each
fusion protein refer to the amino acid at the beginning of the
HN protein-specific sequence). In addition, GST-HN fusion
proteins with overlapping deletions of the carboxyl-terminal
region of the AB sequence were made (GST-A131, GST-A118,
GST-A93, and GST-A76) (numbers in each fusion protein
refer to the amino acid at the end of the HN protein-specific
sequence).
Interactions of HR2 peptides with GST-HN fusion proteins.
Peptides with sequences from the HR2 domain were chemi-
cally synthesized (Fig. 1A). Peptide HR2a-B contains residues
from amino acids 477 to 496 of the F protein. Peptide HR2b-B
contains residues from amino acids 452 to 491 of the F protein
and includes more of the HR2 sequence. Peptide HR2a-B was
previously shown to bind specifically to a peptide with a se-
quence from the HR1 domain of the NDV F protein but not to
nonspecific peptides (41). To determine whether this peptide
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also had an affinity for the membrane-proximal domain of the
HN protein, a blot containing the GST-AB fusion protein was
incubated with peptide HR2a-B, and binding was detected by
using biotin covalently coupled to the peptide. Figure 2A
shows that peptide HR2a-B does bind to the GST-AB fusion
protein (lane 4) but does not bind to GST without the HN
protein sequence (lane 1). Figure 2A also shows that the pep-
tide binds to GST-AB-W, although not as well as to GST-AB.
In addition, the peptide binds to GST fusion proteins missing
different amounts of the AB amino-terminal sequence. The
GST-65B fusion protein is missing 16 amino acids present in
GST-AB, but its binding is similar to that detected for GST-
AB. GST-124B, which contains only amino acids 124 to 152,
binds to the peptide even better than GST-AB. Figure 2B
shows the same blot stained with Coomassie blue. The
amounts of GST and GST fusion proteins in the blot are
similar; thus, binding cannot be accounted for by different
amounts of fusion proteins in the blot.
In initial experiments, purified, nondenatured GST fusion
proteins were spotted on Immobilon P, and the blots were
incubated with peptide HR2a-B as previously described for the
detection of an interaction of this peptide with an F protein
HR1 peptide. The results obtained with this protocol were
identical (data not shown) to those shown in Fig. 2, in which
GST fusion proteins were denatured prior to transfer to Im-
mobilon P. GST-124B bound HR2a-B, while GST-A118 did
not.
The results shown in Fig. 2A suggest that the sequences in
the GST-124B fusion protein are sufficient for the binding of
peptide HR2a-B. To determine whether the peptide will also
bind to sequences more amino terminal to the 124B sequence,
the binding of peptide HR2a-B to GST-124B was compared to
its binding to GST-A118 (Fig. 2C and D). The peptide did not
bind to GST-A118.
The blot shown in Fig. 2C and D contained a fivefold range
of concentrations of fusion proteins in order to determine
whether binding was dependent upon protein concentrations.
The results, quantitated by densitometry, are shown in Fig. 3A.
Clearly, peptide binding to GST-124B increased with increas-
ing amounts of the fusion protein, while no binding to either
GST or GST-A118 was detected at any protein concentration.
Similar results were obtained with a longer HR2 peptide,
HR2b-B. No binding was detected to GST-A118, while the
peptide bound to GST-124B (Fig. 3B). In addition, the degrees
of binding of both HR2 peptides to GST-124B were virtually
identical.
These results implicate amino acids 124 to 152 in HR2
binding. To verify this conclusion, GST fusion proteins with
overlapping deletions of the carboxyl-terminal AB sequence
were tested for interactions with peptides HR2a-B and
FIG. 2. Binding of peptide HR2a-B to GST fusion proteins. (A and C) Binding of peptide HR2a-B to GST fusion proteins containing HN
protein sequences. Binding was detected by using the biotin label on the peptide as described in Materials and Methods. (B and D) Total protein
on blots shown in panels A and C, respectively, as detected by Coomassie blue staining. (A and B) Equivalent amounts of GST fusion proteins
(indicated at the top of panel A and on the side of panel B), as determined by preliminary analysis of Coomassie blue-stained gels containing cell
extracts, were loaded in the lanes. (C and D) Different relative amounts (5, 3, 2, and 1) of GST fusion proteins (indicated at the top of
panel C and on the side of panel D) were loaded in the lanes.
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HR2b-B. Blots similar to those shown in Fig. 2C were quanti-
tated; the results obtained with peptide HR2b-B are shown in
Fig. 4A. Loading of the GST fusion proteins was quantitated
by Coomassie blue staining. Clearly, only GST-A131 showed
any binding to the peptide. This fusion protein contains a short
sequence in common with the GST-124B fusion protein, sug-
gesting that it is this sequence or a sequence between amino
acids 118 and 131 that is responsible for the slight binding
detected. Identical results were obtained with peptide HR2a-B
(data not shown).
FIG. 3. HR2 peptides bind only to HN protein sequences from amino acids 124 to 152. The binding of peptides HR2a-B and HR2b-B to GST
fusion proteins containing only the amino-terminal (GST-A118) or only the carboxyl-terminal (GST-124B) sequences of the membrane-proximal
domain of the HN protein was evaluated. The binding of each peptide to a fivefold or fourfold range of GST fusion protein concentrations in blots
similar to those shown in Fig. 2C was quantitated by densitometry. (A) Results of binding of peptide HR2a-B to GST-124B and to GST-A118.
(B) Results of binding of peptide HR2b-B to GST-124B and to GST-A118. Identical results were obtained in three separate experiments.
FIG. 4. Binding of HR2b-B to the HN protein membane-proximal sequence with overlapping deletions. Blots similar to those shown in Fig.
2C were incubated with HR2b-B, and binding was quantitated as described in the legends to Fig. 2 and 3. (A) Results of binding to the HN protein
membrane-proximal sequence with overlapping deletions of the carboxyl-terminal region compared to binding to a GST fusion protein containing
the entire membrane-proximal sequence (GST-AB). (B) Results of binding to the membrane-proximal sequence with overlapping deletions of the
amino terminus compared to binding to a GST fusion protein containing the entire membrane-proximal sequence (GST-AB). Identical results
were obtained in three separate experiments.
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Similarly, the binding of peptide HR2b-B to GST fusion
proteins with overlapping deletions of the amino-terminal re-
gion of the AB sequence was evaluated. Binding of the peptide
to GST-77B and GST-97B was virtually the same as binding to
GST-AB. Interestingly, the level of binding of the peptide to
GST-124B was higher than that to the longer GST fusion
proteins. Perhaps the conformation of the HN protein se-
quence in the longer GST fusion proteins in the blot was
slightly different from that in the GST-124B fusion protein,
decreasing the affinity of the peptide for the 124B sequence
present in the longer GST fusion proteins.
GST fusion proteins with sequences past amino acid 152 did
not show increased binding to either peptide (data not shown).
GST fusion proteins containing sequences more amino termi-
nal to amino acid 49 were not made because of potential difficul-
ties with the hydrophobicity of this transmembrane domain
sequence.
Fusion promotion activities of HN proteins with mutations
in the 124B region. The results described above implicate the
HN protein domain from amino acids 124 to 152 in interac-
tions with the F protein HR2 domain. However, no mutational
analyses of this region of the HN protein have been reported;
thus, it is difficult to assess the significance of these results to
the fusion promotion activity of the intact protein. To deter-
mine whether this region of the HN protein is indeed involved
in fusion promotion activity, mutant proteins with single amino
acid changes at two different amino acids in the middle of this
region were characterized for their fusion promotion activities.
The isoleucine residue at amino acid 133 was changed to
leucine and the leucine residue at amino acid 140 was changed
to alanine to produce HN-I133L and HN-L140A. Since the
only residues in the HR2 domain that influence fusion are
those in the leucine zipper motif (16, 23), the I133 and L140
residues were chosen as likely candidates for interactions with
this motif. The two mutant proteins were expressed at wild-
type levels (data not shown) and were expressed on cell sur-
faces at levels comparable to that of the wild type (Table 1).
The attachment activities and neuraminidase activities of the
proteins are also shown in Table 1. The neuraminidase activ-
ities of the mutants were 41 and 57% that of the wild type,
while the attachment activities, as measured by red blood cell
binding, were 144 and 50% that of the wild type.
These mutations affected syncytium formation (Fig. 5A).
FIG. 5. Fusion promotion activities of HN protein mutants. (A) Kinetics of syncytium formation directed by wild-type F protein (Fwt) in the
presence of wild-type HN protein (HNwt), HN-I133L, and HN-L140A. Identical results were obtained in two separate experiments. (B) Fusion
promotion activities of mutant HN proteins as measured by content mixing as described in Materials and Methods. The values obtained with
wild-type HN protein were set at 100%. Identical results were obtained in three separate experiments.
TABLE 1. Properties of mutant proteins
DNA
Mean  SD % wild-typea
Surface expressionb
Activity
Attachmentc Neuraminidased
HN wild type 100 100 100
HN-I133L 127  18 144  21 41  5
HN-L140A 118  13 50  4 57  13
a Values were from at least three separate experiments.
b Determined by FACS analysis as described in Materials and Methods.
c Defined as the binding of avian red blood cells to monolayers of cells trans-
fected with wild-type or mutant HN cDNAs. Binding was quantitated by mea-
suring the hemoglobin released after lysis of the attached red blood cells.
d Neuraminidase activity of molecules at the surfaces of transfected cells was
measured as previously described (24, 26).
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Interestingly, these mutant proteins could mediate some syn-
cytium formation, but the kinetics of formation of the syncytia
were considerably slower than those of the wild type. The
fusion promotion activities of these mutant proteins were also
determined by content mixing (Fig. 5B). This measure of the
fusion promotion activities of the mutant HN proteins also
indicates a defect in these activities of the proteins. These
combined results indicate that alterations in this region of the
HN protein can affect the fusion promotion activities of the
protein.
HR2 peptide binding to mutant GST fusion proteins. The
fusion activities of the mutant HN proteins could be due to
differences in binding to the HR2 domain of the F protein. To
determine whether the amino acid mutations affect the binding
of the GST-124B sequence to HR2 sequences, peptide HR2b-B
was incubated with blots containing increasing amounts of the
GST-124B fusion protein with changes at positions corre-
sponding to amino acids 133 and 140. Binding to the resulting
blots was quantitated as described in the legends to Fig. 2 and
3; the results are shown in Fig. 6. GST-124B with an I-to-A
change at position 133 and GST-124B with an L-to-A change
at position 140 both showed significantly less binding to the
peptide than wild-type GST-124B. Thus, amino acid changes in
the HN protein domain that interacts with HR2 sequences can
affect binding to the HR2 peptide. Thus, the phenotype of
intact mutant HN proteins could be accounted for by altered
interactions with the HR2 domain of the intact F protein.
DISCUSSION
Fusion mediated by most paramyxovirus F proteins requires
not only proteolytic cleavage of F0 but also coexpression of the
viral attachment protein (11). The attachment activity of the
protein is necessary but not sufficient. Based on the original
observation by Hu and Compans that the requirement for HN
protein in fusion is virus specific (8), it has been proposed that
there is a type-specific interaction between the paramyxovirus
HN and F proteins necessary for fusion, an interaction that is
likely related to F protein activation (10, 11).
Because of properties of hybrid HN proteins with sequences
from two different HN proteins, it seemed likely that the HN
protein membrane-proximal ectodomain is involved in the in-
teraction with F protein (5, 31, 36). The F protein interacting
domains are not clear. However, given the proximity of the HN
domain implicated to the membrane, it seemed reasonable to
hypothesize that a membrane-proximal domain of the F pro-
tein may be involved in HN protein interactions. The HR2
domain is a likely candidate since this domain is adjacent to the
F protein TM domain. Furthermore, a complex of HR2 with
the HN protein membrane-proximal domain would serve to
prevent HR1-HR2 complex formation until fusion activation.
We, therefore, asked if the F protein HR2 domain could com-
plex with a sequence from the HN protein membrane-proximal
domain.
Using synthetic peptides, we demonstrated an interaction
between the F protein HR2 sequences and sequences derived
from the membrane-proximal domain of the HN protein. This
is the first report of a direct identification of an F protein
domain that may be involved in HN protein interaction. There
is one report characterizing domains in hybrid F proteins that
may be involved in type-specific interactions with HN proteins
(35). In this study, numerous domains were implicated includ-
ing the HR2 domain. Another recent report provides indirect
evidence for an interaction of a peptide with the Sendai virus
F protein HR2 sequence to Sendai virus HN protein (33).
Using overlapping deletions of the HN protein sequence we
FIG. 6. Binding of HR2 peptides to HN sequences with single amino acid changes. Different concentrations of GST, GST-124B, GST-124B-
I133L, and GST-124B-L140A fusion proteins were blotted on Immobilon P as described in the legend to Fig. 2. Peptide HR2b-B was added to
the blot, and binding was detected as described in the legend to Fig. 2 and Materials and Methods. The amount of binding was quantitated as
described in the legends to Fig. 3 and 4. Results are the averages of three separate experiments.
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found a specific interaction between the HR2 peptides and
sequence from amino acids 124 to 152 of the HN protein
sequence but little interaction with more amino-terminal se-
quences. That the sequence from amino acids 124 to 152 is
involved in binding to an F sequence was not surprising since
HN protein chimeras containing NDV HN protein membrane-
proximal sequence must include amino acid 141 to confer
NDV F protein specificity (5). It was surprising, however, that
amino acids 49 to 118 did not bind the HR2 sequences. Mu-
tation of this region, between amino acids 80 and 110, of the
HN protein did eliminate the fusion promotion activity of the
protein (28). Perhaps the domain from amino acids 80 to 110
of HN protein affects the conformation of the region from
amino acids 124 to 152 or this region interacts with another F
protein domain.
The region from amino acids 124 to 152 of the HN protein
has not been previously characterized by mutation. Therefore,
to determine directly if this domain in the intact HN protein
has a role in fusion promotion, point mutations were made at
amino acids 133 and 140. Indeed, both mutations affected
fusion promotion activity without significantly affecting the sur-
face expression. Furthermore, mutant I133L had attachment
activity higher than that of the wild type, and so a lack of
attachment activity cannot account for the phenotype of this
mutant. Mutant L140A had approximately 50% the attach-
ment activity of the wild type, a decrease that could not totally
account for the decrease in fusion promotion. The neuramin-
idase activities of the mutant proteins were decreased by ap-
proximately 60 and 30%. It is unlikely that this decrease could
directly account for the decrease in fusion promotion since
neuraminidase activity may be significantly reduced without
affecting fusion promotion (2, 25). These combined results
suggest the region from amino acids 124 to 152 is involved in
fusion promotion. Furthermore, these amino acid alterations
affected the binding of the HR2 peptide to this HN protein
sequence as measured by the binding of the HR2 peptide to
GST fusion proteins. Thus, it is possible that altered interac-
tion between the HR2 domain of the F protein and the HN
protein could account for defective fusion promotion activities
of the mutant HN proteins.
FIG. 7. Location of the 124B domain in the two conformations of the HN protein. Shown are space-filling representations of the two forms of
NDV HN protein as determined by Crennell et al. (3). The representations were constructed by using the Protein Explorer Program (University
of Massachusetts) with the coordinates reported by Crennell et al. (1e8t and 1e8v). The structures are colored according to the positions within
the sequences, with dark blue representing the most amino-terminal sequences and red representing the most carboxyl-terminal sequences.
Selected amino acids in the region from amino acids 124 to 152 are indicated. (A and C) Side views of the two forms of the HN protein dimer.
(B and D) Underside (membrane-proximal side) of the dimer.
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Our results do not rule out the possibility that other regions
of both the HN and F proteins interact. Indeed, a hybrid HN
protein containing only amino acids 55 to 141 of the NDV HN
protein did not work with the NDV F protein (5). Adding the
NDV TM domain or separately adding the globular head do-
main was necessary for type-specific fusion promotion. This
result would suggest that while the membrane-proximal do-
main may be necessary it is not sufficient for a type-specific
interaction necessary for fusion. Other reports also implicate
more carboxyl-terminal sequences in the globular head domain
of the HN protein in type-specific interactions (31, 36).
Two models have been proposed for the role of the HN
protein-F protein interaction, models that differ in the role of
attachment in inducing conformational changes in F protein
required for the onset of fusion (10, 15, 26, 30). One model
proposes that HN and F proteins interact only after HN pro-
tein receptor binding and this interaction initiates F protein
conformational changes required for fusion (10, 17). An alter-
native model is that HN and F proteins form a metastable
complex prior to HN protein attachment (29, 32, 34). Such a
complex would prevent HR1-HR2 interactions that would
form in F proteins expressed without HN protein. In this sec-
ond model, HN protein attachment with a concomitant con-
formational change would release the F protein stimulating the
cascade of F protein conformational changes required for fu-
sion, changes that result in the formation of the six stranded
coiled coil composed of HR1 and HR2 domains. Both models
include the idea that the HN protein undergoes a conforma-
tional change upon attachment. Based on the reactivity of cell
surface F protein to a peptide antibody specific for the HR1
domain, we have presented evidence consistent with the sec-
ond model (15) as has Takimoto et al. (30). Our finding of an
interaction between the HN protein membrane-proximal do-
main and the F protein HR2 domain is also consistent with this
second model.
The crystal structure of the NDV HN protein has been
solved by Crennell et al. (3). Remarkably, Crennell et al. re-
ported two different conformational forms of the HN protein,
one was crystallized at pH 4.5 with an empty catalytic site (Fig.
7A), while the other was crystallized at more neutral pH and
contained a filled site (Fig. 7B). Crennell et al. have proposed
that the two forms represent alternative conformations of the
HN protein, one pre attachment and the other postattachment.
They have suggested that the molecule undergoes a conforma-
tional transition upon attachment and cleavage of sialic acid, a
transition that may be linked to fusion activation. While the
membrane-proximal domain from amino acids 49 to 123 was
missing from these structures due to the method of solubiliza-
tion of material for crystallization, the domain from amino
acids 124 to 152 was present in the structure and formed part
of the globular head domain. Interestingly, the domain impli-
cated here in binding to F protein HR2 (Fig. 7, dark blue
residues) is in a very different orientation in the molecule in
the two forms of HN protein. In the structure with an empty
catalytic site, the domain lays along the side of the molecule
(Fig. 7A and B) while in the structure with a filled site, the
domain is located on the underside of the globular head do-
main (Fig. 7C and D). Movement from one form to the other
may serve to alter the association of this domain from the F
protein HR2 domain, activating the F protein.
It must be noted, however, that the NDV HN protein used
for determination of structure was from a strain of NDV that
does not form disulfide-linked HN protein dimers. In other
strains of NDV, including strain AV used here, a disulfide
bond covalently links cysteine residues at position 123. As
noted by Crennell et al. (3), in the structure of the attachment-
ready form (Fig. 7A and B), the residues at position 123 in
adjacent molecules are too far apart to form a disulfide link-
age. This observation raises the possibility that the prebinding
form of the HN protein from the AV strain is not in precisely
the conformation shown in Fig. 7A and B. However, the do-
main may well be in a conformation different from that in the
structure with a filled catalytic site.
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